research-student

Recent Conferences

Recent Presentations (2014-2016)

  1. Abu-Raddad LJ. “In country generation of data and estimates”. First Meeting of the Viral Hepatitis Strategic Information and Modelling Reference Group; June 2016; Geneva, Switzerland.
  2. Abu-Raddad LJ. “Epidemiology of sexually transmitted infections in the Middle East and North Africa: knowns and unknowns”. 17th IUSTI World Congress; May 2016; Marrakesh, Morocco.
  3. Akbarzadeh V, Mumtaz G, Awad SF, Weiss HA, Abu-Raddad LJ. “Thresholds for a sustainable or concentrated HIV epidemic among people who inject drugs: mathematical modelling analyses”. 17th IUSTI World Congress; May 2016; Marrakesh, Morocco.
  4. Smolak A, Chemaitelly H, Abu-Raddad LJ. “Explaining the heterogeneity in the prevalence of chlamydia trachomatis across the Middle East and North Africa”. 17th IUSTI World Congress; May 2016; Marrakesh, Morocco.
  5. Smolak A, Abu-Raddad LJ. “The epidemiology of trichomoniasis in the Middle East and North Africa: systematic review and meta-analysis”. 17th IUSTI World Congress; May 2016; Marrakesh, Morocco.
  6. Abu-Raddad LJ. “Epidemiological data review on hepatitis  C ”. Strategic and Technical Consultation on Viral Hepatitis in the Eastern Mediterranean Region; April 2016; Casablanca, Morocco.
  7. Abu-Raddad LJ, Awad SF, Sundaram M. “The age structured mathematical (ASM) model: approach and methodology”. Fast Tracking VMMC in Combination Prevention: Global Stakeholder Consultation on Modelling, Targeting and Evaluation UNAIDS and WHO; March 2016; Geneva, Switzerland.
  8. Awad SF, Abu-Raddad LJ, Sgaier S, Sundaram M. “Can circumcision of HIV-positive males benefit VMMC programs in Africa?”. Fast Tracking VMMC In Combination Prevention: Global Stakeholder Consultation on Modelling, Targeting and Evaluation UNAIDS and WHO; March 2016; Geneva, Switzerland.
  9. Chemaitelly H, Sibai AM, Rizk A. “Self-rated health disparities among disadvantaged older adults in ethnically-diverse urban neighborhoods in a Middle Eastern country”. Qatar Foundation Annual Research Conference 2016; March 2016; Doha, Qatar.
  10. Al Rifai R, Abu-Raddad LJ. “Caesarean delivery and its associated factors in Egypt: analysis of population-based surveys, 2005-2014”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2016; Doha, Qatar.
  11. Awad SF, Tambatamba BC, Mohamoud YA, Lau FK, Reed JB, Njeuhmeli E, Abu-Raddad LJ. “A novel analytic framework to investigate voluntary medical male circumcision program efficiency gains through sub-population prioritisation: insights from application to Zambia”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2016; Doha, Qatar.
  12. Ayoub H, Chemaitelly H, Abu-Raddad LJ. “Are we underestimating HCV infection spontaneous clearance?”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2016; Doha, Qatar.
  13. Chaabna K, Kouyoumjian PS, Abu-Raddad LJ. “Hepatitis C virus prevalence in the Horn of Africa sub-region of the Middle East and North Africa: systematic review and meta-analysis”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2016; Doha, Qatar.
  14. Chemaitelly H, Chaabna K, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in the Fertile Crescent: systematic review and meta-analysis”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2016; Doha, Qatar.
  15. Kouyoumjian PS, Chemaitelly H, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in Egypt: systematic review and meta-analysis”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2016; Doha, Qatar.
  16. Mahmud S, Akbarzadeh V, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in Iran: systematic review and meta-analysis”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2016; Doha, Qatar.
  17. Abu-Raddad LJ. “Epidemiological data review on hepatitis C”. Strategic and Technical Consultation on Viral Hepatitis in the Eastern Mediterranean Regions; April 2016; Casablanca, Morocco.
  18. Awad SF, Abu-Raddad LJ, Sgaier S, Sundaram M. “The age structured mathematical (ASM) model: prioritization of sub-populations”. Fast tracking VMMC in Combination Prevention: Global Stakeholder Consultation on Modelling, Targeting and Evaluation UNAIDS and WHO; March 2016; Geneva, Switzerland.
  19. Awad SF, Sgaier S, Ncube G, Xaba S, Mugurungi O, Mhangara M, Lau FK, Mohamoud Y, Abu-Raddad LJ. “Voluntary medical male circumcision in Zimbabwe: a reevaluation of the scale-up plan”. Epidemics5: Fifth International Conference on Infectious Disease Dynamics; December 2015; Florida, U.S.A.
  20. Ayoub H, Chemaitelly H, Abu-Raddad LJ. “Are we underestimating hepatitis C virus Infection spontaneous clearance?”. Epidemics5: Fifth International Conference on Infectious Disease Dynamics; December 2015; Florida, U.S.A.
  21. Chemaitelly H, Chaabna K, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in the Fertile Crescent: systematic review and meta-analysis”. The Liver Meeting 2015, AASLD’s 66th Annual Meeting; November 2015; California, U.S.A.
  22. Awad SF, Sgaier S, Tambatamba BC, Mohamoud YA, Lau FK, Reed JB, Njeuhmeli E, Abu-Raddad LJ. “A novel analytic framework to investigate voluntary medical male circumcision program efficiency gains through sub-population prioritization: insights from application to Zambia”. World STI & HIV Congress; September 2015; Brisbane, Australia.
  23. Awad SF, Sgaier S, Abu-Raddad LJ. “Enhancing program efficiency of voluntary medical male circumcision for HIV prevention: a novel modelling approach”. Innovations in Program Design for Sexual and Reproductive Health: A Program Science Symposium; September 2015; Brisbane, Australia.
  24. Awad SF, Sgaier S, Lau FK, Mohamoud Y, Tambatamba BC, Kripke KE, Thomas AG, Bock N, Reed JB, Njeuhmeli E, Abu-Raddad LJ. “Circumcision of HIV-positive males will not undermine the benefits of voluntary medical male circumcision programs in Africa”. World STI & HIV Congress; September 2015; Brisbane, Australia.
  25. Chemaitelly H, Mahmud S, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis”. World STI & HIV Congress; September 2015; Brisbane, Australia.
  26. Cuadros DF, Abu-Raddad LJ. “Incorporating spatial variability to generate sub-national estimates of HIV prevalence”. World STI & HIV Congress; September 2015; Brisbane, Australia.
  27. Cuadros DF, Abu-Raddad LJ. “Spatial epidemiology of HIV infection in sub-Saharan Africa: a methodology for identifying populations at high risk of HIV infection in sub-Saharan Africa”. Innovations in Program Design for Sexual and Reproductive Health: A Program Science Symposium; September 2015; Brisbane, Australia.
  28. Mumtaz G, Weiss H, Vickerman P, Larke N, Abu-Raddad LJ. “Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa”. 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD); June 2015; Berlin, Germany.
  29. Abu-Raddad LJ. “Hepatitis C virus infection in the Middle East and North Africa: a public health perspective”. Weill Cornell Medical College in Qatar Grand Rounds; June 2015; Doha, Qatar.
  30. Abu-Raddad LJ. “Characterizing HCV prevalence and transmission in the Middle East and North Africa”. The First Meeting of the National Focal Points for Viral Hepatitis; June 2015; Cairo, Egypt.
  31. Chaabna K, Abu-Raddad LJ. “HCV epidemiology in the Horn of Africa: systematic review and meta-analyses”. MENA HCV Epidemiology Synthesis Project Meeting; June 2015; Cairo, Egypt.
  32. Chaabna K, Abu-Raddad LJ. “Hepatitis C virus prevalence in the Horn of Africa sub-region of the Middle East and North Africa: systematic review and meta-analysis”. 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD); June 2015; Berlin, Germany.
  33. Chaabna K, Abu-Raddad LJ. “HCV epidemiology in Arab Maghreb countries: systematic review and meta-analyses”. MENA HCV Epidemiology Synthesis Project Meeting; June 2015; Cairo, Egypt.
  34. Chemaitelly H, Abu-Raddad LJ. “HCV epidemiology in Afghanistan: systematic review and meta-analyses”. MENA HCV Epidemiology Synthesis Project Meeting; June 2015; Cairo, Egypt.
  35. Chemaitelly H, Abu-Raddad LJ. “HCV epidemiology in Fertile Crescent: systematic review and meta-analyses”. MENA HCV Epidemiology Synthesis Project Meeting; June 2015; Cairo, Egypt.
  36. Cuadros DF, Miller DF, Nagelkerke N, Abu-Raddad LJ. “Are diabetics less likely to have a cleared hepatitis C virus infection?”. 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD); June 2015; Berlin, Germany.
  37. Mahmud S, Abu-Raddad LJ. “HCV epidemiology in the Gulf: systematic review and meta-analyses”. MENA HCV Epidemiology Synthesis Project Meeting; June 2015; Cairo, Egypt.
  38. Mahmud S, Abu-Raddad LJ. “HCV epidemiology in Iran: systematic review and meta-analyses”. MENA HCV Epidemiology Synthesis Project Meeting; June 2015; Cairo, Egypt.
  39. Akbarzadeh V, Abu-Raddad LJ. “Can HCV prevalence predict HIV epidemic potential among people who inject drugs? Preliminary theoretical results”. 6th International Tehran Hepatitis Conference (THC6); May 2015; Tehran, Iran.
  40. Chaabna K, Kouyoumjian PS, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in the Horn of Africa: A systematic review and meta-analysis methods and preliminary findings”. 6th International Tehran Hepatitis Conference (THC6); May 2015; Tehran, Iran.
  41. Cuadros DF, Abu-Raddad LJ. “The geography of HIV infection in Tanzania”. Center for Disease Control and Prevention Meeting; May 2015; Dar es Salaam, Tanzania.
  42. Cuadros DF, Abu-Raddad LJ. “The geography of HIV infection in sub-Saharan Africa: Valleys, dams and islands”. American Association of Geographers 2015 meeting; April 2015; Chicago, U.S.A.
  43. Mumtaz G, Weiss H, Thomas S, Riome SK, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D, Abu-Raddad LJ. “People who inject drugs in the Middle East and North Africa: Over half a million individuals and emerging HIV epidemics”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  44. Smolak A, Zarrabian B, Abu-Raddad LJ. “The epidemiology of chlamydia in the Middle East and North Africa: A systematic review and meta-analysis preliminary findings”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  45. Akbarzadeh V, Abu-Raddad LJ. “HCV prevalence can predict HIV epidemic potential among people who inject drugs: Preliminary and initial results”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  46. Awad SF, Sgaier S, Lau FK, Mohamoud Y, Abu-Raddad LJ. “Could circumcision of HIV-positive males provide benefits to voluntary medical male circumcision programs?”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  47. Ayoub H, Kanso M, Ainseba B, Langlais M. “An optimal vaccination strategy for rebuilding immunity in lymphopenia conditions”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  48. Chaabna K, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in Yemen: A systematic review and meta-analysis”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  49. Christos P, Chemaitelly H, Abu-Raddad LJ, Zirie M, Deleu D, Mushlin A. “Identifying key factors for type II diabetes mellitus prevention interventions in Qatar”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  50. Cuadros DF, Awad SF, Abu-Raddad LJ. “Use of routine HIV testing data for early detection of HIV epidemics in hidden subpopulations”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  51. Mahmud S, Abu-Raddad LJ. “The prevalence of hepatitis C virus in Iran: Preliminary results”. Weill Cornell Medical College-Qatar Annual Research Retreat; February 2015; Doha, Qatar.
  52. Awad SF, Abu-Raddad LJ. “The impact of scaling-up voluntary medical male circumcision as an HIV intervention in South Sudan”. Qatar Foundation Annual Research Conference 2014; November 2014; Doha, Qatar.
  53. Chaabna K, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in Yemen: A systematic review and meta-analysis”. Qatar Foundation Annual Research Conference 2014; November 2014; Doha, Qatar.
  54. Christos P, Chemaitelly H, Abu-Raddad LJ, Ali Zirie M, Deleu D, Mushlin A. “Identifying key factors for type II diabetes mellitus prevention interventions in Qatar”. Qatar Foundation Annual Research Conference November 2014; Doha, Qatar.
  55. Kouyoumjian PS, Haddad P, El Rhilani H, Latifi A, El Kettani A, Alami K, Bennani A, Abu-Raddad LJ. “Mapping new HIV infections in Morocco by modes of transmission model in 2013”. Qatar Foundation Annual Research Conference 2014; November 2014; Doha, Qatar.
  56. Mumtaz G, Weiss H, Thomas S, Riome SK, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D, Abu-Raddad LJ. “HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis”. Qatar Foundation Annual Research Conference 2014; November 2014; Doha, Qatar.
  57. Smolak A, Mohamoud Y, Abu-Raddad LJ. “The epidemiology of gonorrhea in the Middle East and North Africa: A systematic review and meta-analysis”. 18th International Union against Sexually Transmitted Infections Asia Pacific Conference; November 2014; Bangkok, Thailand.
  58. Smolak A, Abu-Raddad LJ. “The epidemiology of chlamydia in the Middle East and North Africa: A systematic review and meta-analysis”. 18th International Union against Sexually Transmitted Infections Asia Pacific Conference; November 2014; Bangkok, Thailand.
  59. Benova L, Mohamoud Y, Calvert C, Abu-Raddad LJ. “Vertical transmission of hepatitis C: Systematic review and meta-analysis”. American Association for the Study of Liver Diseases (AASLD)/European Association for the Study of the Liver (EASL) 2014 Special Conference on Hepatitis C September 2014; New York, U.S.A.
  60. Mohamoud Y, Abu-Raddad LJ. “Quantifying hepatitis C virus prevalence in the Middle East and North Africa: Interim results”. American Association for the Study of Liver Diseases (AASLD)/European Association for the Study of the Liver (EASL) 2014 Special Conference on Hepatitis C September 2014; New York, U.S.A.
  61. Abu-Raddad LJ. “HIV and malaria: when elephants flirt”. Short Course on Infectious Disease Mathematical Modeling, University of Tokyo; August 2014; Tokyo, Japan.
  62. Abu-Raddad LJ. “A role for co-infections in the HIV epidemic in sub-Saharan Africa?”. Graduate University for Advanced Studies; August 2014; Hayama, Japan.
  63. Abu-Raddad LJ. “A role for co-infections in fueling the large HIV epidemics in sub-Saharan Africa?”. Joint Annual Meeting of the Japanese Society for Mathematical Biology and the Society for Mathematical Biology; August 2014; Osaka, Japan.
  64. Awad SF, Cuadros DF, Abu-Raddad LJ. “Characterizing HIV prevalence distribution across sub-populations at variable levels of sexual behavior”. Joint Annual Meeting of the Japanese Society for Mathematical Biology and the Society for Mathematical Biology; August 2014; Osaka, Japan.
  65. Chemaitelly H, Abu-Raddad LJ. “HIV epidemiology among stable couples in sub-Saharan Africa: A mathematical modeling perspective”. Joint Annual Meeting of the Japanese Society for Mathematical Biology and the Society for Mathematical Biology; August 2014; Osaka, Japan.
  66. Cuadros DF, Awad SF, Abu-Raddad LJ. “Drivers of the HIV infection in sub-Saharan Africa: A geographical approach”. Joint Annual Meeting of the Japanese Society for Mathematical Biology and the Society for Mathematical Biology; August 2014; Osaka, Japan.
  67. Bennani A, Kouyoumjian PS, Haddad P, El Rhilani H, Alami K, Latifi A, El Kettani A, Abu-Raddad LJ. “The distribution of new HIV infections by the national modes of transmission model in Morocco in 2013”. 20th International AIDS Conference; July 2014; Melbourne, Australia.
  68. Cuadros DF, Awad SF, Abu-Raddad LJ. “Are “cold spots” of male circumcision driving the spatial distribution of HIV infection in Tanzania?”. 20th International AIDS Conference; July 2014; Melbourne, Australia.
  69. Kouyoumjian PS, Abu-Raddad LJ. “Understanding the epidemiological overlap between HIV and HSV-2: A window for quantifying sexual risk behavior?”. Joint Annual Meeting of the Japanese Society for Mathematical Biology and the Society for Mathematical Biology; July 2014; Osaka, Japan.
  70. Abu-Raddad LJ. “Characterizing the emerging HIV epidemics in the Middle East and North Africa”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  71. Awad SF, Abu-Raddad LJ. “The impact of scaling up voluntary medical male circumcision in South Sudan”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  72. Benova L, Mohamoud Y, Calvert C, Abu-Raddad LJ. “Vertical transmission of hepatitis C: Systematic review and meta-analysis”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  73. Chaabna K, Newton R, Vanhems P, Laouar M, Forman D, Boudiaf Z, Soerjomataram I. “All-cause mortality in HIV-positive patients in six Algerian regions before and during the era of highly active antiretroviral therapy (HAART)”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): A Scientific Workshop to Promote Research Collaboration; May 2014; Doha, Qatar.
  74. Chemaitelly H, Abu-Raddad LJ, Miller DF. “Lack of an evident role for public awareness on the prevention of hepatitis C transmission in Egypt”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  75. Cuadros DF, Branscum A, Miller DF, Abu-Raddad LJ. “Spatial epidemiology of hepatitis C virus infection in Egypt”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  76. Kouyoumjian PS, Chaabna K, Mumtaz G, Omori R, Abu-Raddad LJ. “Identifying regional variation in the association between HIV and HSV-2 prevalence: Systematic review and meta-analyses”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  77. Mohamoud Y, Abu-Raddad LJ. “Quantifying hepatitis C virus prevalence across the Middle East and North Africa”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  78. Mumtaz G, Weiss H, Thomas S, Riome S, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D, Abu-Raddad LJ. “HIV and HCV among people who inject drugs in the Middle East and North Africa”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  79. Omori R, Chemaitelly H, Abu-Raddad LJ. “Estimation of the formation dynamics of casual sexual partnerships”. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA): NIH-QNRF Scientific Workshop; May 2014; Doha, Qatar.
  80. Cuadros DF, Branscum A, Miller DF, Abu-Raddad LJ. “Spatial epidemiology of hepatitis C virus infection in Egypt”. Association of American Geographers Annual Meeting; April 2014; Florida, U.S.A.
  81. Abu-Raddad LJ. “Role of biological co-factors in HIV epidemiology and impact of biomedical HIV prevention interventions”. QF R&D Research Outcome Seminar on Biomedical and Health; March 2014; Doha, Qatar.
  82. Awad SF, Sgaier S, Abu-Raddad LJ. “Key results of the application of the age structured model (ASM) in Zambia and Zimbabwe”. Voluntary Medical Male Circumcision Regional Modeling Meeting; March 2014; Johannesburg, South Africa.
  83. Cuadros DF, Abu-Raddad LJ. “Incorporating spatial variability to generate sub-national estimates of HIV prevalence”. Technical Consultation on Methods for Generating Sub-National Estimates of HIV Epidemiology to Support Country Program Planning and Evaluation; March 2014; Nairobi, Kenya.
  84. Awad SF, Sgaier S, Abu-Raddad LJ. “The Zimbabwe age structured model (ASM) for estimating the impact of voluntary medical male circumcision as an HIV intervention: Approach and methodology”. National Voluntary Medical Male Circumcision Program - Ministry of Health; February 2014; Harare, Zimbabwe.
  85. Awad SF, Sgaier S, Abu-Raddad LJ. “The Zambia age structured model (ASM) for estimating the impact of voluntary medical male circumcision as an HIV intervention: Approach and methodology”. National Voluntary Medical Male Circumcision Program - Ministry of Community Development, Mother and Child Health; February 2014; Lusaka, Zambia.
  86. Awad SF, Sgaier S, Abu-Raddad LJ. “The Zambia age structured model (ASM) for estimating the impact of voluntary medical male circumcision as an HIV intervention: Findings and discussion”. National Voluntary Medical Male Circumcision Program - Ministry of Community Development, Mother and Child Health; February 2014; Lusaka, Zambia.
  87. Awad SF, Sgaier S, Abu-Raddad LJ. “The Zimbabwe age structured model (ASM) for estimating the impact of voluntary medical male circumcision as an HIV intervention: Findings and discussion”. National Voluntary Medical Male Circumcision Program - Ministry of Health; February 2014; Harare, Zimbabwe.
  88. Al-Othman F, Chemaitelly H, Abu-Raddad LJ. “The epidemiologic association between Islamic affiliation and HIV infection in sub-Saharan Africa”. Weill Cornell Medical College - Qatar Annual Research Retreat; January 2014; Doha, Qatar.
  89. Awad SF, Abu-Raddad LJ. “Generic results for the effectiveness of voluntary medical male circumcision as an HIV intervention in sub-Saharan Africa”. Weill Cornell Medical College - Qatar Annual Research Retreat; January 2014; Doha, Qatar.
  90. Chemaitelly H, Abu-Raddad LJ. “Sources of HIV incidence within stable sexual couples in sub-Saharan Africa”. Weill Cornell Medical College - Qatar Annual Research Retreat; January 2014; Doha, Qatar.
  91. Cuadros DF, Awad SF, Abu-Raddad LJ. “Targeting the hotspots: Spatial distribution of the HIV epidemic in sub-Saharan Africa”. Weill Cornell Medical College - Qatar Annual Research Retreat; January 2014; Doha, Qatar.
  92. Haddad P, Mahfoud Z. “Religiosity and waterpipe smoking association: results from the multivariable logistic regression with and without propensity-score adjustment”. Weill Cornell Medical College-Qatar Annual Research Forum; January 2014; Doha, Qatar.
  93. Kouyoumjian PS, Mumtaz G, Vickerman P, Abu-Raddad LJ. “Global ecological study of HIV and HSV-2 prevalence”. Weill Cornell Medical College-Qatar Annual Research Retreat; January 2014; Doha, Qatar.
  94. Mohamoud Y, Abu-Raddad LJ. “The epidemiology of hepatitis C virus in the Arabian Gulf region: A systematic review and meta-analysis”. Weill Cornell Medical College - Qatar Annual Research Retreat; January 2014; Doha, Qatar.
  95. Omori R, Abu-Raddad LJ. “Can immunity against re-infection contribute to explaining the age distribution of infection for Chlamydia trachomatis?”. Weill Cornell Medical College - Qatar Annual Research Retreat; January 2014; Doha, Qatar.